NEW YORK (360Dx) – The US Food and Drug Administration has cleared Roche's Elecsys BRAHMS PCT assay for an expanded use to aid in antibiotic therapy decision-making, the company announced on Friday.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.